In India, the incidence of breast cancer is 25.8 in 100000 women each year with a mortality rate of 12.7 out of every 100000 ...

Individual patient data from neoadjuvant randomized breast cancer clinical trials with available data on pathologic complete ...

For patients with high-risk, early-stage estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 ...

Complete Breast Care, a specialized breast oncology practice led by Dr. Beth Anglin, has integrated with Advanced ...

A new UK trial using artificial intelligence (AI) in breast cancer screening could significantly increase the speed and ...

“Pathologic complete response benefits were generally consistent across subgroups, including higher-risk categories. Approximately 15% of patients with breast cancer have triple-negative breast ...